Suture Anchor Devices Market By Type (Absorbable Suture Anchors, Non-Absorbable Suture Anchors), By Material (Metallic, Bioabsorbable, Composite, PEEK), By Shape (Knotless Anchors, Screw-in Anchors, Push-in Anchors), By Application (Shoulder Injuries, Knee Injuries, Foot and Ankle Injuries, Hip Injuries, Others), and By End-User (Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles, and Market Forecast, 2025 – 2035.

---

What trends will shape the Suture Anchor Devices Market in the coming years?

The Suture Anchor Devices Market accounted for USD 817.60 Million in 2024 and USD 856.03 Million in 2025 is expected to reach USD 1355.05 Million by 2035, growing at a CAGR of around 4.70% between 2025 and 2035. The Suture Anchor Devices market is an industry that caters to the medical implants in specialty medical surgeries concerned with attaching the soft tissues, e.g., ligaments or tendons, to the bone. Such devices are most frequently used in the shoulder, knee, hip, and foot procedures such as rotator cuff repair work, ACL reconstruction, and other sports injuries. Suture anchors may be constructed of materials, including metal, bioabsorbable polymers, or composite materials, and each material type has varying advantages depending on the clinical use. The anchor is placed into the bone, and it has sutures attached that help to hold the tissue in one position, which allows natural tissue to heal and regenerate.

Technology has made these devices stronger, more bio-compatible, and biodegradable, which resulted in an enhancement of surgical results as well as the recovery time of the patient. The increased number of orthopedic injuries as a result of an aging population, increasing involvement in sports, and increasing awareness about the advantages of minimally invasive surgeries is growing the demand. Moreover, the trend towards arthroscopic surgeries, which are not invasive and easier to recover from in comparison with other procedures, contributes to market growth. As the healthcare system shifts towards efficient and cost-effective means of treatments, the suture anchors device continues to be one of the essential aspects of contemporary orthopedic treatment.

What do industry experts say about the Suture Anchor Devices market trends?

“Suture anchors are broadly used for attaching soft tissue (e.g., tendons, ligaments, and meniscus) to the bone and have become essential devices in sports medicine and during arthroscopic surgery.”

• Dr. Chul‑Hyun Cho, MD, Associate Professor, Department of Orthopedic Surgery, Keimyung University Dongsan Hospital, Korea

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Suture Anchor Devices market?

Is the demand for arthroscopic and minimally invasive surgeries driving the market?

The Suture Anchor Devices market is boosted by the emerging trend of arthroscopic and minimally invasive surgeries. These surgical procedures have multiple advantages, including shortened recovery period, fewer incisions, minimal disfigurement, and postoperative complications, which are the reasons why they are becoming popular among patients and surgeons alike. The use of suture anchor devices is an important input in such processes, particularly in orthopedic repair such as rotator cuff repair and ACL repair, where accuracy and minimum tissue destruction are vital.

The shifted mass use of arthroscopy has contributed extensively to the escalation in usage of bioabsorbable as well as knotless suture anchors because of their applicability in the less invasive procedures. The increased dependence on arthroscopies is corroborated by the fact that more than 450,000 shoulder arthroscopies have been conducted in the United States alone, according to the Agency for Healthcare Research and Quality (AHRQ) data. This trend will affirm the market growth as more suture anchor integration will be adopted in minimally invasive surgical procedures, as healthcare systems want to have cost-effective and efficient surgical solutions.

Are increasing sports-related injuries and trauma cases boosting product usage?

Rising cases of sports injuries and trauma are one of the major growth factors in the Suture Anchor Devices market. Due to the increasing participation in high-impact and repetitive-contact sporting activities, particularly by the knees and shoulders, among youth and young adults, the incidence of tendon and ligament injuries requiring surgery to repair them has also been showing rapid growth.

As an illustration, the U.S. Centers for Disease Control and Prevention (CDC) estimates that each year, 2 million injuries, 500,000 doctor visits, and 30,000 hospitalizations are the result of injuries suffered by high school athletes only. These injuries are very common and are normally accompanied by tearing of the soft tissues in joints like the knees and the shoulder, and the affected areas are quite difficult to surgically fix without the use of suture anchors. As ACL tears, rotator cuff, and ankle ligament injuries become more common, more orthopedic surgeons turn to upgraded systems of anchors.

Do complications like anchor pull-out and bone damage restrain market growth?

Potential issues such as anchor pull-out and bone injury highly inhibit the evolution of the Suture Anchor Devices market. Despite suture anchors being intended to have good fixation, they may fail when the grade of bone is improper positioning, poor, or mechanical overloading, which results in a pull-out or loosening. Such issues can lead to the failure of repairs, re-surgery, and more time in recovery, leaving the patient more concerned about this device as well as their surgeon's trust.

The metallic or rigid anchors may prevent bone healing, induce microfractures, or weaken the bone reliability in elderly patients or patients with osteoporosis. This poses limitations to the anchors in particular populations and casts uncertainty on the long-term outcomes. Secondly, repeated surgeries not only make healthcare expensive, but also make the surgeons unwilling to use more advanced and expensive anchors. Subsequently, these safety-related issues serve as constraints towards the general acceptance of this into the market, particularly in the cost and risk-averse healthcare setting.

Is there potential in developing customizable or patient-specific suture anchors?

Customizable or patient-specific development of suture anchors holds a lot of promise and offers a good opportunity in the Suture Anchor Devices market. Increased efficiency of 3D printing, imaging, and biomaterials is now enabling manufacturers to design the anchors that will match the specific anatomy, bone density, and type of injury in a particular patient. This customization enhances anchor fit, increases the anchor fixation strength, and minimizes the probability of complications, such as pull-out or displacement. Personalized products are especially useful in complicated surgeries or revisions, and the regular sizes of the anchors are not perfectly usable.

Patient-specific anchors can be related to improved clinical results and acceleration of the healing process, as precision medicine becomes even more popular. With hospitals and surgical facilities getting more and more engaged in customized surgical equipment, the prospect of custom-made suture anchors may provide them with a competitive advantage. The innovation holds increased interest in the pediatric, geriatric, and anatomically difficult cases, thereby providing new growth horizons among manufacturers that deal with advanced orthopedic care.

Could biodegradable nanomaterials enhance healing and offer innovation?

Introducing the use of biodegradable nanomaterials can be an important innovation process in the Suture Anchor Devices market. There are nano-based materials like nano-hydroxyapatite or nanofiber-based composites that can be specifically designed to integrate with the natural bone architecture, hence osteointegration can be improved, and faster tissue regeneration achieved. These materials provide control degradation when utilized in suture anchors, ensuring fewer long-term complications and, on the other hand, providing mechanical recession during the healing period. The additional functional value brought by their biocompatibility and potential to transport therapeutic compounds, such as antibiotics or growth factors.

Orthopedic surgery is gradually heading towards biologically active implants, and biodegradable nanomaterials hold the potential to overturn the concept of anchor surgery, particularly when considering the patient demographics as young and active individuals. These materials are actively under investigation at research institutions and biomedical engineering centers, and they may potentially result in the next-generation anchors with better results in terms of patient safety and outcomes. This new technology is relevant to the market trend that explores safer, smarter, and more efficient implant technology to achieve high-growth opportunities among the early adopters and developers.

What are the key market segments in the Suture Anchor Devices industry?

Based on the Type, the Suture Anchor Devices Market is classified into Absorbable Suture Anchors, Non-Absorbable Suture Anchors. The most dominant segment of the Suture Anchor Devices market is the Absorbable Suture Anchors. The popularity of these anchors is associated with the capacity to naturally break down in the body with time, meaning that they may not require surgical removal as may be the case with other anchors. They minimize the risk of complications of the implants in the long term and prove particularly beneficial in active and young patients.

Surgeons prefer absorbable fasteners in surgeries such as rotator cuff and ACL since long-term retention of foreign substances is objectionable. The use of technology has also made them stronger and reliable, such that they can be compared with non-absorbable ones. They have also been found largely acceptable in the surgeries of the minimal invasive procedures, which also supports their dominance in the market.

Based on the Technology, the Suture Anchor Devices Market is classified into Metallic, Bioabsorbable, Composite, and PEEK (Polyether Ether Ketone). Bioabsorbable is the most prominent material in the Suture Anchor Devices market by material. They easily dissolve in the body without causing complications in the long-term process, and there is no need to undergo another surgery to have the implant removed. They are also readily applied in orthopedic surgery, such as rotator cuff or ACL repair, because they can be used in biological repair.

Since surgeons can use bioabsorbable anchors to avoid tissue irritation and provide secure early fixation, they choose the former. Inventions in the field of polymer science have enhanced their properties and degradation kinetics, thus they have become a reliable option in contemporary orthopedic surgeries. Their dominance is further enhanced by their growing application in the minimally invasive procedure.

Which regions are leading the Suture Anchor Devices market, and why?

The North American Suture Anchor Devices market is led by the United States, which thrives on high-quality healthcare infrastructure and extensive popularity of minimally invasive treatment procedures, and a robust presence of medical device industry titans. The area is also well endowed with the number of orthopedic surgical cases, especially in the sports injuries and age-related degenerative musculoskeletal illnesses and conditions, such as rotator cuff tears and anterior cruciate ligament (ACL) tears. The market is also boosted by good confess policies by way of good reimbursement policies and rising expenditure on healthcare.

The topic of technological innovation is one of the priorities, and U.S.-based companies constantly work on bioabsorbable and all-suture anchors in order to enhance patient outcomes. There is also good clinical research and surgeon training in the region, which facilitates the use of high surgical techniques. Canada makes some smaller contributions, with the steadily increasing number of elderly people and enhanced orthopedic care.

The Asia-Pacific Suture Anchor Devices market is growing at an alarming rate, due to growing healthcare investments, medical tourism, as well as the awareness of people on better orthopedic practices. The first countries on the list include China, India, Japan, and South Korea, among others, with an increasing number of injuries, osteoarthritis, and traumatological cases driving demand. In terms of technology adoption, the leaders are Japan and South Korea, and in terms of growth potential, there are countries with a great number of patients and with enhanced access to healthcare facilities, such as India and China.

The efforts of the government to update healthcare systems and facilities and local production have promoted the development of the market. Moreover, the increased use of arthroscopic procedures and surgeon training initiatives is positively impacting the adoption of the least invasive anchor systems. Nevertheless, the sensitivity to costs and different reimbursement arrangements can pose a challenge to the entry of premium devices.

What does the competitive landscape of the Suture Anchor Devices market look like?

The Suture Anchor Devices market is highly competitive, marked by the involvement of some established global manufacturers and an increasing regional developer. Those that dominate the market include Arthrex, Smith & Nephew, Stryker, and Johnson & Johnson due to their strong product lines, constant investments in research and development, as well as the wide distribution channels. These firms direct their efforts to innovations, especially in bioabsorbable and all-suture anchor technologies, with a view to acquiring a competitive advantage and responding to changing surgical demands. Mid-sized companies and new entrants are also joining the market, with low-priced solutions and niche applications or applications to develop new markets.

Strategic partnerships, acquisitions, and product launches are the order of the day as firms endeavor to grow their market share and develop technological capacity. As an example, players usually partner with hospitals and surgical centers to drive the training and usage of advanced systems of anchors. In addition, increasing patient desire to have minimally invasive surgeries has put more pressure on arthroscopic anchor design. Other market strategy factors include regulatory, clinical outcomes, and price pressure.

Suture Anchor Devices Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Suture Anchor Devices industry?

• In January 2024, Zimmer Biomet's Paragon 28 launched the Grappler Knotless Anchor System and Bridgeline Tape to enhance its foot and ankle soft tissue repair offerings. The Grappler system provides strong fixation without the need for tying knots, while the Bridgeline Tape offers improved tissue compression and load distribution.

Report Coverage:

By Type

• Absorbable Suture Anchors
• Non-Absorbable Suture Anchors

By Material

• Metallic
• Bioabsorbable
• Composite
• PEEK (Polyether Ether Ketone)

By Shape

• Knotless Anchors
• Screw-in Anchors
• Push-in Anchors

By Application

• Shoulder Injuries
• Knee Injuries
• Foot and Ankle Injuries
• Hip Injuries
• Others

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Arthrex, Inc.
• Smith & Nephew plc
• Johnson & Johnson
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• ConMed Corporation
• Medtronic plc
• B. Braun Melsungen AG
• Parcus Medical, LLC
• Biotek
• Wright Medical Group N.V.
• Orthomed S.A.S.
• Tulpar Medical Solutions
• Anika Therapeutics, Inc.
• Teknimed

Frequently Asked Questions (FAQs)